insulin

Can Biocon get a $1B pharma deal for its oral insulin program?

Can Biocon get a $1B pharma deal for its oral insulin program?

Fierce Biotech

Eli Lilly insulin brand paves way for hike in imported drug prices (in India)

Eli Lilly insulin brand paves way for hike in imported drug prices (in India)

Economic Times, India

Submitted by moderatorj on Thu, 06/02/2011 - 14:43

EU clears J&J and DexCom insulin pump and monitor

EU clears J&J and DexCom insulin pump and monitor

Yahoo/AP

Submitted by moderatora on Wed, 03/09/2011 - 15:24

Device News

Johnson & Johnson recalls nearly 400,000 Animas insulin cartridges

Mass Device

News

J&J’s Animas Recalls Five Lots of Leaking Insulin Cartridges

Bloomberg

News

Pfizer Taps Beer Skills to Enter $14 Billion Insulin Market

Bloomberg

News

The $15 Billion Biotech Blockbuster Whose Sales Are Going Up With No End In Sight

Forbes

Submitted by moderatora on Fri, 02/04/2011 - 17:31

Device News

Cellnovo raises $48 million to commercialize "itunes of diabetes care"

Mass Device

News

Biodel leads biotech stocks lower

Marketwatch

News

Novo Confirms Potential in New Insulin but Challenges Remain

Seeking Alpha